Zevra Therapeutics Inc. (ZVRA) — Cash Flow Reinvestment Rate
Zevra Therapeutics Inc. (ZVRA) has a Cash Flow Reinvestment Rate of 1.09x as of September 2025, reinvesting $5.13 Million (capex $554.00K plus investments $-4.58 Million) from operating cash flow of $4.71 Million. See Zevra Therapeutics Inc. (ZVRA) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zevra Therapeutics Inc. Cash Flow Reinvestment Rate (2021–2021)
Historical reinvestment intensity for Zevra Therapeutics Inc. across 1 annual periods. For the full cash flow conversion analysis, see Zevra Therapeutics Inc. operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Zevra Therapeutics Inc. (2021–2021)
Year-by-year capital reinvestment analysis for Zevra Therapeutics Inc.. See Zevra Therapeutics Inc. (ZVRA) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 1.50x | $15.63 Million | $10.44 Million | $102.00K | — |